From April 15, 2024 to May 22, 2024, the company has repurchased 1,247,200 shares, representing 0.27% for CNY 49.99 million. With this, the company has completed the repurchase of 1,247,200 shares, representing 0.27% for CNY 49.99 million under the buyback announced on April 15, 2024.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.16 CNY | +2.65% |
|
-6.28% | -56.59% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.59% | 1.74B | |
-19.73% | 8.22B | |
+70.43% | 4.38B | |
+11.61% | 2.81B | |
-2.45% | 2.66B | |
-15.14% | 1.75B | |
-16.69% | 1.47B | |
+20.62% | 1.24B | |
-49.43% | 1.03B | |
+16.99% | 970M |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on April 15, 2024.